Impact of myelodysplasia‐related mutations on 2022 European LeukemiaNet genetic risk classification in de novo acute myeloid leukemia with normal karyotype
Srija Shanker,Robert P. Hasserjian,Yazan Madanat,Olga K. Weinberg,Miguel D. Cantu
DOI: https://doi.org/10.1002/ajh.27518
IF: 13.265
2024-11-01
American Journal of Hematology
Abstract:De novo normal karyotype AML 2017ELN and 2022ELN Genetic Risk Category Changes and Overall Survival in Induction Treated Patients.
hematology
What problem does this paper attempt to address?